Daniel Edwin Painter

Search results

• 2020

  Mutation Profiles Identify Distinct Clusters of Lower Risk Myelodysplastic Syndromes with Unique Clinical and Biological Features and Clinical Endpoints

  Malcovati, L., Crouch, S., De Graaf, A. O., Sandmann, S., Tobiasson, M., Kosmider, O., van der Reijden, B. A., Painter, D., Van de Loosdrecht, A. A., Symeonidis, A., Cermak, J., Clappier, E., Preudhomme, C., Stauder, R., Mittelman, M., Germing, U., Bowen, D., Fenaux, P., Van Marrewijk, C., Smith, A., & 5 othersDugas, M., Hellstrom Lindberg, E., de Witte, T. M., Fontenay, M. & Jansen, J., 5 Nov 2020, In: Blood. 136, Suppl. 1, 29.

  Research output: Contribution to journal › Meeting abstract › peer-review

• Survival Outcomes for Plasmablastic Lymphoma: An International, Multicentre Study By the Australasian Lymphoma Alliance

  Ciaccio, P. R. D., Polizzotto, M. N., Cwynarski, K., Burton, C., Jiamsakul, A., Bower, M., Kuruvilla, J., Montoto, S., McKay, P., Osborne, W., Milliken, S., Linton, K., Manos, K., Kassam, S., Doo, N. W., Watson, A-M., Fedele, P. L., Yannakou, C. K., Hunt, S., Renshaw, H., & 9 othersThakrar, N., Smith, A., Painter, D., Maxwell, A., Liu, Q., Dhairyawan, R., Ferguson, G., Pickard, K. & Hamad, N., 5 Nov 2020, In: Blood. 136, Suppl.1, p. 1-2 2 p.

  Research output: Contribution to journal › Meeting abstract › peer-review
• 2019

  Defining Burkitt-like lymphoma with 11q aberration in a specialised UK haematopathology diagnostic service

  Barrans, S., Painter, D., van Hoppe, S., Smith, A., Sha, C., Cucco, F., Du, M., Westhead, D., Davies, A., Johnson, P., Roman, E. & Burton, C., Jun 2019, In: Hematological Oncology. 37, S2, p. 143-144 2 p.

  Research output: Contribution to journal › Meeting abstract › peer-review

• Longitudinal Analyses of Diagnostic-Relapse Biopsies of Diffuse Large B Cell Lymphoma Reveal a Poor Risk Subset of ABC Patients Based on the Expression of a 30 Gene Panel

  Bewicke-Copley, F., Korfi, K., Araf, S., Kumar, E. A., Cummin, T. E. C., Ashton-Key, M., Barrans, S., Van Hoppe, S., Burton, C., Elshiekh, M., Rule, S., Crosbie, N., Clear, A. J., Calaminici, M., Scott, D. W., Rimsza, L. M., Geetha, M., Sha, C., Bentley, M. A., Nagano, A., & 10 othersDavies, A., Painter, D., Smith, A., Gribben, J. G., Naresh, K., Westhead, D. R., Okosun, J., Johnson, P., Wang, J. & Fitzgibbon, J., 13 Nov 2019, In: Blood. 134, Suppl.1, 2769.

  Research output: Contribution to journal › Meeting abstract › peer-review

• Population-based outcomes in large b-cell lymphona by WHO subtype: findings from the UK's haematological malignancy research network

  Patmore, R., Smith, A., Barrans, S., Painter, D., Howell, D., Burton, C. & Roman, E., 12 Jun 2019, In: Hematological Oncology. 37, S2, p. 196-197 2 p.

  Research output: Contribution to journal › Meeting abstract › peer-review
• 2016

  Similarity Search Methods As an Alternative to Sub-Type Characterisation in Aggressive Lymphomas

  Chulin, S., Barrans, S., Jack, A., Burton, C., Smith, A. G., Roman, E., Painter, D. E., Crouch, S., Tooze, R., Care, M. A. & Westhead, D. R., 2 Dec 2016, In: Blood. 128, 22, p. 3052 1 p.

  Research output: Contribution to journal › Meeting abstract › peer-review

• Validation of Plasma Cell Immunophenotype As a Biomarker to Identify High-Risk Smoldering Myeloma

  Rawstron, A. C., Smith, A. G., de Tute, R. M., Painter, D. E., Roman, E. & Owen, R. G., 2 Dec 2016, In: Blood. 128, 22, 1 p.

  Research output: Contribution to journal › Meeting abstract › peer-review
• 2015

  Poor Outcomes in HIV Negative and HIV Positive Patients with Plasmablastic Lymphoma (PBL) in a Population Based Patient Study

  Appleby, N., Cullen, R., Painter, D. E., Smith, A. G., Roman, E., Barrans, S., O'Connor, S., Burton, C., Jack, A. S., Owen, R. G. & Tooze, R., 3 Dec 2015, In: Blood. 126, 23, p. 2021 1 p.

  Research output: Contribution to journal › Meeting abstract › peer-review
• 2013

  Bone Marrow Staging For Lymphoma: A Re-Evaluation Of Clinical Utility

  Jack, A., Painter, D. E., Smith, A. G., Roman, E., de Tute, R. & Patmore, R., 15 Nov 2013, In: Blood. 122, 21, p. 4278-4278 4278.

  Research output: Contribution to journal › Meeting abstract › peer-review

• Differences in Medical Cost and Survival Between Trial and Non-Trial Patients with Acute Myeloid Leukaemia: A UK Population-Based Propensity Analysis

  Wang, H. I., Aas, F. E., Roman, E., Howell, D., Painter, D. E. & Smith, A. G., 1 Nov 2013, In: Value in Health. 16, 7, p. A394 PCN15.

  Research output: Contribution to journal › Meeting abstract › peer-review

  File

• Social Inequality Is An Important Risk Factor For Death From Chronic Myeloid Leukaemia: Findings From a UK Population-Based Cohort

  Smith, A. G., Roman, E., Painter, D. E., Howell, D., smith, G., Evans, P., Patmore, R. & Jack, A., 15 Nov 2013, In: Blood. 122, 21, p. 4036-4036 4036.

  Research output: Contribution to journal › Meeting abstract › peer-review

• The Prognosis Of Transformed Follicular Lymphoma Is Determined By Prior Exposure To Chemotherapy

  Jack, A., Smith, A. G., de Tute, R., Painter, D. E., Roman, E. & Patmore, R., 15 Nov 2013, In: Blood. 122, 21, p. 78-78 78.

  Research output: Contribution to journal › Meeting abstract › peer-review
• 2011

  A Unified Prognostic Model for Myelodysplastic Syndrome and Acute Myeloid Leukaemia Based on Flow Cytometric Blast Count

  Smith, A. G., Crouch, S., Painter, D. E., Roman, E., Cullen, M. J., Bennett, F. L., Cargo, C. & Jack, A., 18 Nov 2011, In: Blood. 118, 21, 1736.

  Research output: Contribution to journal › Meeting abstract › peer-review